145
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Modulatory effect of myricitrin against chromosome instability and cytostasis induced by bleomycin and oxaliplatin in CHO-K1 cells

, , , , ORCID Icon & ORCID Icon
Pages 726-735 | Received 04 Jan 2022, Accepted 30 May 2022, Published online: 14 Jun 2022

References

  • Ahangarpour, A., et al., 2018. Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell. Cell Stress & Chaperones, 23 (4), 773–781.
  • Ahangarpour, A., et al., 2019. Antioxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticles on streptozotocin-nicotinamideinduced diabetic nephropathy in type 2 diabetic male mice. Iranian Journal of Basic Medical Sciences, 22 (12), 1424–1431.
  • Alqudah, M.A.Y., et al., 2018. Vitamin E protects human lymphocytes from genotoxicity induced by oxaliplatin. Drug and Chemical Toxicology, 41 (3), 281–286.
  • Amorim, B.S., et al., 2019. Advanced understanding of phylogenetic relationships, morphological evolution and biogeographic history of the mega-diverse plant genus Myrcia and its relatives (Myrtaceae: Myrteae). Molecular Phylogenetics and Evolution, 138, 65–88.
  • Atha, D.H., et al., 2020. Genotoxic effects of etoposide, bleomycin, and ethyl methanesulfonate on cultured CHO cells: analysis by GC-MS/MS and comet assay. Journal of Nucleic Acids, 2020, 8810105.
  • Arumugam, P., et al., 2019. Anticancer effect of fucoidan on cell proliferation, cell cycle progression, genetic damage and apoptotic cell death in HepG2 cancer cells. Toxicology Reports, 6, 556–563.
  • Biso, F.I., et al., 2010. Assessment of DNA damage induced by extracts, fractions and isolated compounds of Davilla nitida and Davilla elliptica (Dilleniaceae). Mutation Research, 702 (1), 92–99.
  • Brandt, J., and Gerrietes, V., 2020. Bleomycin. In: StatPearls. Treasure Island (FL): StatPearls publishing.
  • Bravo, L., 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutrition Reviews, 56 (11), 317–333.
  • Cascaes, M.M., et al., 2015. Constituents and pharmacological activities of Myrcia (Myrtaceae): a review of an aromatic and medicinal group of plants. International Journal of Molecular Sciences, 16 (10), 23881–23904.
  • Cho, Y.H., et al., 2016. Protective effect of onion extract on bleomycin-induced cytotoxicity and genotoxicity in human lymphocytes. International Journal of Environmental Research and Public Health, 13 (2), 227–211.
  • Danesi, C.C., et al., 2012. Genotoxicity testing of combined treatment with cisplatin, bleomycin, and 5-fluorouracil in somatic cells of Drosophila melanogaster. Mutation Research, 747 (2), 228–233.
  • De Flora, S., and Ramel, C., 1988. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 202 (2), 285–306.
  • de Souza, A.P., Lehmann, M., and Dihl, R.R., 2017. Comparative study on the induction of complex genomic alterations after exposure of mammalian cells to carboplatin and oxaliplatin. Drug and Chemical Toxicology, 40 (4), 410–415.
  • Dos Santos, C., et al., 2018. Antioxidative, antiproliferative and antimicrobial activities of phenolic compounds from three Myrcia species. Molecules, 23 (5), 986.
  • Domitrović, R., et al., 2015. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chemico-Biological Interactions, 230, 21–29.
  • Evans, W.E., et al., 1982. Clinical pharmacology of bleomycin and cisplatin. Drug Intelligence & Clinical Pharmacy, 16 (6), 448–458.
  • Fenech, M., 2007. Cytokinesis-block micronucleus cytome assay. Nature Protocols, 2 (5), 1084–1104.
  • Ganaie, M.A., et al., 2019. The protective effect of naringenin on oxaliplatin-induced genotoxicity in mice. Chemical & Pharmaceutical Bulletin, 67 (5), 433–438.
  • Gao, J., et al., 2019. Myricitrin exhibits anti-atherosclerotic and anti-hyperlipidemic effects in diet-induced hypercholesterolemic rats. AMB Express, 9 (1), 1–7.
  • Granata, M.U., et al., 2021. Secondary metabolites profile and physiological leaf traits in wild and cultivated Corylus avellana under different nutritional status. Natural Product Research, 35 (18), 3100–3108.
  • Hintzsche, H., et al., 2017. Fate of micronuclei and micronucleated cells. Mutation Research. Reviews in Mutation Research, 771, 85–98.
  • Hobbs, C.A., et al., 2015. Genotoxicity evaluation of the flavonoid, myricitrin, and its aglycone, myricetin. Food and Chemical Toxicology, 83, 283–292.
  • Howells, L.M., Mitra, A., and Manson, M.M., 2007. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. International Journal of Cancer, 121 (1), 175–183.
  • Jagetia, A., Jha, G., and Jagetia, S., 2007. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival. Journal of Applied Toxicology, 27 (2), 122–132.
  • Jeong, H.G., 1999. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicology Letters, 105 (3), 215–222.
  • Kada, T., and Shimoi, K., 1987. Desmutagens and bio-antimutagens-their modes of action. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 7 (3), 113–116.
  • Kim, H.H., et al., 2013. Flavonoid constituents in the leaves of Myrica rubra sieb. et zucc. with anti-inflammatory activity. Archives of Pharmacal Research, 36 (12), 1533–1540.
  • Lee, T.-H., and Kang, T.-H., 2019. DNA oxidation and excision repair pathways. International Journal of Molecular Sciences, 20 (23), 6092.
  • Li, R., et al., 2020. Myricitrin protects against cisplatin-induced kidney injury by eliminating excessive reactive oxygen species. International Urology and Nephrology, 52 (1), 187–196.
  • Liu, Z., et al., 2018. Preventive effect of curcumin against chemotherapy-induced side-effects. Frontiers in Pharmacology, 9, 1374–1379.
  • OECD. 2014. OECD test guideline. Paris, France: OECD Publishing; Vol. 487. p. 1–26.
  • OECD. 2016. OECD guideline for the testing of chemicals: 487, in vitro mammalian cell micronucleus test. Organisation for economic co-operation and development publishing, (July), 29.
  • Patil, S.L., et al., 2021. Efeito protetor in vitro de rutina e quercetina contra danos genéticos induzidos por radiação em linfócitos humanos. Indian Journal of Nuclear Medicine, 32 (4), 289–295.
  • Pendyala, L., and Creaven, P., 1993. In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Research, 53 (24), 5970–5976.
  • Perdomo, R.T., et al., 2020. Myricitrin from combretum lanceolatum exhibits inhibitory effect on DNA-topoisomerase type IIa and protective effect against in vivo doxorubicin-induced mutagenicity. Journal of Medicinal Food, 0 (0), 1–9.
  • Povirk, L.F., 1996. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutation Research, 355 (1–2), 71–89.
  • Povirk, L.F., and Austin, M.J.F., 1991. Genotoxicity of bleomycin. Mutation Research/Reviews in Genetic Toxicology, 257 (2), 127–143.
  • Ramos, A.S., et al., 2019. Pedra-ume caá fruit: an Amazon cherry rich in phenolic compounds with antiglycant and antioxidant properties. Food Research International, 123, 674–683.
  • Rottenberg, S., Disler, C., and Perego, P., 2021. The rediscovery of platinum-based cancer therapy. Nature Reviews. Cancer, 21 (1), 37–50.
  • Sarkar, M.K., Mahapatra, S.K., and Vadivel, V., 2020. Oxidative stress mediated cytotoxicity in leukemia cells induced by active phyto-constituents isolated from traditional herbal drugs of West Bengal. Journal of Ethnopharmacology, 251, 112527.
  • Savi, D.C., Aluizio, R., and Glienke, C., 2019. Brazilian plants: an unexplored source of endophytes as producers of active metabolites. Planta Medica, 85 (8), 619–636.
  • Sevgi, K., Tepe, B., and Sarikurkcu, C., 2015. Antioxidant and DNA damage protection potentials of selected phenolic acids. Food and Chemical Toxicology, 77, 12–21.
  • Shimosaki, S., et al., 2011. Anti-allergic effect of the flavonoid myricitrin from Myrica rubra leaf extracts in vitro and in vivo. Natural Product Research, 25 (4), 374–380.
  • Silva, I.D., et al., 2000. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chemico-Biological Interactions, 124 (1), 29–51.
  • Slockzynsk, K., et al., 2014. Antimutagenic compounds and their possible mechanisms of action. Journal of Applied Genetics, 55 (2), 273–285.
  • Sun, G. b., et al., 2013. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice. Toxicology and Applied Pharmacology, 271 (1), 114–126.
  • Umezawa, H., et al., 1966. New antibiotics, bleomycin A and B. Journal of Antibiotics., 19, 200–209.
  • Valli, M., et al., 2018. The potential contribution of the natural products from Brazilian biodiversity to bioeconomy. Anais da Academia Brasileira de Ciencias, 90 (1 Suppl 1), 763–778.
  • Von Borstel, R.C., and Higgins, J.A., 1998. Janus carcinogens and mutagens. Mutation Research, 402 (1–2), 321–329.
  • Waters, M.D., et al., 1996. Activity profiles of antimutagens: in vitro and in vivo data. Mutation Research, 350, 109–129.
  • Xu, R., et al., 2013. Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro. Food Chemistry, 138 (1), 48–53.
  • Yilmaz, D., et al., 2016. Anti-genotoxic effect of naringin against bleomycin-induced genomic damage in human lymphocytes in vitro. Drug and Chemical Toxicology, 39 (2), 119–123.
  • Yoshino, M., et al., 1999. Prooxidant activity of flavonoids: copper-dependent strand breaks and the formation of 8-hydroxy-2'-deoxyguanosine in DNA. Molecular Genetics and Metabolism, 68 (4), 468–472.
  • Zhang, Y., et al., 2018. Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance. Cancer Science, 109 (1), 94–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.